97 related articles for article (PubMed ID: 10718972)
1. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
[TBL] [Abstract][Full Text] [Related]
2. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
3. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
4. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
[TBL] [Abstract][Full Text] [Related]
5. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
6. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
7. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
9. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
10. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
[TBL] [Abstract][Full Text] [Related]
11. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
12. Development of a European organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy.
Spry N; Halkett G; Aoun S; Spry J; Yeoh E
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):522-8. PubMed ID: 18374505
[TBL] [Abstract][Full Text] [Related]
13. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
15. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
16. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
Davies AH; Larsson G; Ardill J; Friend E; Jones L; Falconi M; Bettini R; Koller M; Sezer O; Fleissner C; Taal B; Blazeby JM; Ramage JK;
Eur J Cancer; 2006 Mar; 42(4):477-84. PubMed ID: 16412628
[TBL] [Abstract][Full Text] [Related]
17. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
Chow E; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
[TBL] [Abstract][Full Text] [Related]
18. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
20. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]